世界のがん幹細胞（CSC）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer Stem Cell Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1070 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、がん幹細胞（CSC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞培養、細胞分離、細胞分析、分子分析、その他）、用途別市場規模（がん幹細胞治療、標的CSC）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん幹細胞（CSC）の市場動向 ・企業の競争状況、市場シェア ・がん幹細胞（CSC）の種類別市場規模（細胞培養、細胞分離、細胞分析、分子分析、その他） ・がん幹細胞（CSC）の用途別市場規模（がん幹細胞治療、標的CSC） ・がん幹細胞（CSC）の北米市場規模2016-2027（アメリカ、カナダ） ・がん幹細胞（CSC）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん幹細胞（CSC）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん幹細胞（CSC）の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん幹細胞（CSC）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific, Inc.、AbbVie, Inc.、Merck KGaA、Bionomics、Lonza、Stemline Therapeutics, Inc.、Miltenyi Biotec、PromoCell GmbH、MacroGenics, Inc.、OncoMed Pharmaceuticals, Inc.、Irvine Scientific、STEMCELL Technologies Inc.、Sino Biological Inc.、BIOTIME, Inc.） ・結論

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.

Market Analysis and Insights: Global Cancer Stem Cell Market
The global Cancer Stem Cell market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Stem Cell market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Stem Cell market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Stem Cell market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Stem Cell market.

Global Cancer Stem Cell Scope and Market Size
Cancer Stem Cell market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Stem Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others

Segment by Application
Stem Cell Based Cancer Therapy
Targeted CSCs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
Bionomics
Lonza
STEMCELL Technologies Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Stem Cell Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Culturing
1.2.3 Cell Separation
1.2.4 Cell Analysis
1.2.5 Molecular Analysis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Stem Cell Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stem Cell Based Cancer Therapy
1.3.3 Targeted CSCs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Stem Cell Market Perspective (2016-2027)
2.2 Cancer Stem Cell Growth Trends by Regions
2.2.1 Cancer Stem Cell Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Stem Cell Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Stem Cell Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Stem Cell Industry Dynamic
2.3.1 Cancer Stem Cell Market Trends
2.3.2 Cancer Stem Cell Market Drivers
2.3.3 Cancer Stem Cell Market Challenges
2.3.4 Cancer Stem Cell Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cell Players by Revenue
3.1.1 Global Top Cancer Stem Cell Players by Revenue (2016-2021)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Stem Cell Revenue
3.4 Global Cancer Stem Cell Market Concentration Ratio
3.4.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2020
3.5 Cancer Stem Cell Key Players Head office and Area Served
3.6 Key Players Cancer Stem Cell Product Solution and Service
3.7 Date of Enter into Cancer Stem Cell Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Stem Cell Breakdown Data by Type
4.1 Global Cancer Stem Cell Historic Market Size by Type (2016-2021)
4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2022-2027)

5 Cancer Stem Cell Breakdown Data by Application
5.1 Global Cancer Stem Cell Historic Market Size by Application (2016-2021)
5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Stem Cell Market Size (2016-2027)
6.2 North America Cancer Stem Cell Market Size by Type
6.2.1 North America Cancer Stem Cell Market Size by Type (2016-2021)
6.2.2 North America Cancer Stem Cell Market Size by Type (2022-2027)
6.2.3 North America Cancer Stem Cell Market Size by Type (2016-2027)
6.3 North America Cancer Stem Cell Market Size by Application
6.3.1 North America Cancer Stem Cell Market Size by Application (2016-2021)
6.3.2 North America Cancer Stem Cell Market Size by Application (2022-2027)
6.3.3 North America Cancer Stem Cell Market Size by Application (2016-2027)
6.4 North America Cancer Stem Cell Market Size by Country
6.4.1 North America Cancer Stem Cell Market Size by Country (2016-2021)
6.4.2 North America Cancer Stem Cell Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cancer Stem Cell Market Size (2016-2027)
7.2 Europe Cancer Stem Cell Market Size by Type
7.2.1 Europe Cancer Stem Cell Market Size by Type (2016-2021)
7.2.2 Europe Cancer Stem Cell Market Size by Type (2022-2027)
7.2.3 Europe Cancer Stem Cell Market Size by Type (2016-2027)
7.3 Europe Cancer Stem Cell Market Size by Application
7.3.1 Europe Cancer Stem Cell Market Size by Application (2016-2021)
7.3.2 Europe Cancer Stem Cell Market Size by Application (2022-2027)
7.3.3 Europe Cancer Stem Cell Market Size by Application (2016-2027)
7.4 Europe Cancer Stem Cell Market Size by Country
7.4.1 Europe Cancer Stem Cell Market Size by Country (2016-2021)
7.4.2 Europe Cancer Stem Cell Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Stem Cell Market Size (2016-2027)
8.2 Asia-Pacific Cancer Stem Cell Market Size by Type
8.2.1 Asia-Pacific Cancer Stem Cell Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Stem Cell Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Stem Cell Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Stem Cell Market Size by Application
8.3.1 Asia-Pacific Cancer Stem Cell Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Stem Cell Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Stem Cell Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Stem Cell Market Size by Region
8.4.1 Asia-Pacific Cancer Stem Cell Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Stem Cell Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Stem Cell Market Size (2016-2027)
9.2 Latin America Cancer Stem Cell Market Size by Type
9.2.1 Latin America Cancer Stem Cell Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Stem Cell Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Stem Cell Market Size by Type (2016-2027)
9.3 Latin America Cancer Stem Cell Market Size by Application
9.3.1 Latin America Cancer Stem Cell Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Stem Cell Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Stem Cell Market Size by Application (2016-2027)
9.4 Latin America Cancer Stem Cell Market Size by Country
9.4.1 Latin America Cancer Stem Cell Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Stem Cell Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Stem Cell Market Size (2016-2027)
10.2 Middle East & Africa Cancer Stem Cell Market Size by Type
10.2.1 Middle East & Africa Cancer Stem Cell Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Stem Cell Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Stem Cell Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Stem Cell Market Size by Application
10.3.1 Middle East & Africa Cancer Stem Cell Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Stem Cell Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Stem Cell Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Stem Cell Market Size by Country
10.4.1 Middle East & Africa Cancer Stem Cell Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Stem Cell Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 AbbVie, Inc.
11.2.1 AbbVie, Inc. Company Details
11.2.2 AbbVie, Inc. Business Overview
11.2.3 AbbVie, Inc. Cancer Stem Cell Introduction
11.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.2.5 AbbVie, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Cancer Stem Cell Introduction
11.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2016-2021)
11.3.5 Merck KGaA Recent Development
11.4 Bionomics
11.4.1 Bionomics Company Details
11.4.2 Bionomics Business Overview
11.4.3 Bionomics Cancer Stem Cell Introduction
11.4.4 Bionomics Revenue in Cancer Stem Cell Business (2016-2021)
11.4.5 Bionomics Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Cancer Stem Cell Introduction
11.5.4 Lonza Revenue in Cancer Stem Cell Business (2016-2021)
11.5.5 Lonza Recent Development
11.6 Stemline Therapeutics, Inc.
11.6.1 Stemline Therapeutics, Inc. Company Details
11.6.2 Stemline Therapeutics, Inc. Business Overview
11.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction
11.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.6.5 Stemline Therapeutics, Inc. Recent Development
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Details
11.7.2 Miltenyi Biotec Business Overview
11.7.3 Miltenyi Biotec Cancer Stem Cell Introduction
11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2016-2021)
11.7.5 Miltenyi Biotec Recent Development
11.8 PromoCell GmbH
11.8.1 PromoCell GmbH Company Details
11.8.2 PromoCell GmbH Business Overview
11.8.3 PromoCell GmbH Cancer Stem Cell Introduction
11.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2016-2021)
11.8.5 PromoCell GmbH Recent Development
11.9 MacroGenics, Inc.
11.9.1 MacroGenics, Inc. Company Details
11.9.2 MacroGenics, Inc. Business Overview
11.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction
11.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.9.5 MacroGenics, Inc. Recent Development
11.10 OncoMed Pharmaceuticals, Inc.
11.10.1 OncoMed Pharmaceuticals, Inc. Company Details
11.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
11.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction
11.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Details
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Cancer Stem Cell Introduction
11.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2016-2021)
11.11.5 Irvine Scientific Recent Development
11.12 STEMCELL Technologies Inc.
11.12.1 STEMCELL Technologies Inc. Company Details
11.12.2 STEMCELL Technologies Inc. Business Overview
11.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction
11.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.12.5 STEMCELL Technologies Inc. Recent Development
11.13 Sino Biological Inc.
11.13.1 Sino Biological Inc. Company Details
11.13.2 Sino Biological Inc. Business Overview
11.13.3 Sino Biological Inc. Cancer Stem Cell Introduction
11.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.13.5 Sino Biological Inc. Recent Development
11.14 BIOTIME, Inc.
11.14.1 BIOTIME, Inc. Company Details
11.14.2 BIOTIME, Inc. Business Overview
11.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction
11.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
11.14.5 BIOTIME, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer Stem Cell Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Culturing
Table 3. Key Players of Cell Separation
Table 4. Key Players of Cell Analysis
Table 5. Key Players of Molecular Analysis
Table 6. Key Players of Others
Table 7. Global Cancer Stem Cell Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Stem Cell Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Stem Cell Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cancer Stem Cell Market Share by Regions (2016-2021)
Table 11. Global Cancer Stem Cell Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cancer Stem Cell Market Share by Regions (2022-2027)
Table 13. Cancer Stem Cell Market Trends
Table 14. Cancer Stem Cell Market Drivers
Table 15. Cancer Stem Cell Market Challenges
Table 16. Cancer Stem Cell Market Restraints
Table 17. Global Cancer Stem Cell Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cancer Stem Cell Market Share by Players (2016-2021)
Table 19. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cell as of 2020)
Table 20. Ranking of Global Top Cancer Stem Cell Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cancer Stem Cell Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Stem Cell Product Solution and Service
Table 24. Date of Enter into Cancer Stem Cell Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cancer Stem Cell Revenue Market Share by Type (2016-2021)
Table 28. Global Cancer Stem Cell Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cancer Stem Cell Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cancer Stem Cell Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cancer Stem Cell Revenue Market Share by Application (2016-2021)
Table 32. Global Cancer Stem Cell Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cancer Stem Cell Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cancer Stem Cell Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cancer Stem Cell Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million)
Table 64. Thermo Fisher Scientific, Inc. Company Details
Table 65. Thermo Fisher Scientific, Inc. Business Overview
Table 66. Thermo Fisher Scientific, Inc. Cancer Stem Cell Product
Table 67. Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 68. Thermo Fisher Scientific, Inc. Recent Development
Table 69. AbbVie, Inc. Company Details
Table 70. AbbVie, Inc. Business Overview
Table 71. AbbVie, Inc. Cancer Stem Cell Product
Table 72. AbbVie, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 73. AbbVie, Inc. Recent Development
Table 74. Merck KGaA Company Details
Table 75. Merck KGaA Business Overview
Table 76. Merck KGaA Cancer Stem Cell Product
Table 77. Merck KGaA Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 78. Merck KGaA Recent Development
Table 79. Bionomics Company Details
Table 80. Bionomics Business Overview
Table 81. Bionomics Cancer Stem Cell Product
Table 82. Bionomics Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 83. Bionomics Recent Development
Table 84. Lonza Company Details
Table 85. Lonza Business Overview
Table 86. Lonza Cancer Stem Cell Product
Table 87. Lonza Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 88. Lonza Recent Development
Table 89. Stemline Therapeutics, Inc. Company Details
Table 90. Stemline Therapeutics, Inc. Business Overview
Table 91. Stemline Therapeutics, Inc. Cancer Stem Cell Product
Table 92. Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 93. Stemline Therapeutics, Inc. Recent Development
Table 94. Miltenyi Biotec Company Details
Table 95. Miltenyi Biotec Business Overview
Table 96. Miltenyi Biotec Cancer Stem Cell Product
Table 97. Miltenyi Biotec Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 98. Miltenyi Biotec Recent Development
Table 99. PromoCell GmbH Company Details
Table 100. PromoCell GmbH Business Overview
Table 101. PromoCell GmbH Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 102. PromoCell GmbH Recent Development
Table 103. MacroGenics, Inc. Company Details
Table 104. MacroGenics, Inc. Business Overview
Table 105. MacroGenics, Inc. Cancer Stem Cell Product
Table 106. MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 107. MacroGenics, Inc. Recent Development
Table 108. OncoMed Pharmaceuticals, Inc. Company Details
Table 109. OncoMed Pharmaceuticals, Inc. Business Overview
Table 110. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Product
Table 111. OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 112. OncoMed Pharmaceuticals, Inc. Recent Development
Table 113. Irvine Scientific Company Details
Table 114. Irvine Scientific Business Overview
Table 115. Irvine Scientific Cancer Stem Cell Product
Table 116. Irvine Scientific Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 117. Irvine Scientific Recent Development
Table 118. STEMCELL Technologies Inc. Company Details
Table 119. STEMCELL Technologies Inc. Business Overview
Table 120. STEMCELL Technologies Inc. Cancer Stem Cell Product
Table 121. STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 122. STEMCELL Technologies Inc. Recent Development
Table 123. Sino Biological Inc. Company Details
Table 124. Sino Biological Inc. Business Overview
Table 125. Sino Biological Inc. Cancer Stem Cell Product
Table 126. Sino Biological Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 127. Sino Biological Inc. Recent Development
Table 128. BIOTIME, Inc. Company Details
Table 129. BIOTIME, Inc. Business Overview
Table 130. BIOTIME, Inc. Cancer Stem Cell Product
Table 131. BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
Table 132. BIOTIME, Inc. Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Stem Cell Market Share by Type: 2020 VS 2027
Figure 2. Cell Culturing Features
Figure 3. Cell Separation Features
Figure 4. Cell Analysis Features
Figure 5. Molecular Analysis Features
Figure 6. Others Features
Figure 7. Global Cancer Stem Cell Market Share by Application: 2020 VS 2027
Figure 8. Stem Cell Based Cancer Therapy Case Studies
Figure 9. Targeted CSCs Case Studies
Figure 10. Cancer Stem Cell Report Years Considered
Figure 11. Global Cancer Stem Cell Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cancer Stem Cell Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cancer Stem Cell Market Share by Regions: 2020 VS 2027
Figure 14. Global Cancer Stem Cell Market Share by Regions (2022-2027)
Figure 15. Global Cancer Stem Cell Market Share by Players in 2020
Figure 16. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cell as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cancer Stem Cell Revenue in 2020
Figure 18. Global Cancer Stem Cell Revenue Market Share by Type (2016-2021)
Figure 19. Global Cancer Stem Cell Revenue Market Share by Type (2022-2027)
Figure 20. North America Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cancer Stem Cell Market Share by Type (2016-2027)
Figure 22. North America Cancer Stem Cell Market Share by Application (2016-2027)
Figure 23. North America Cancer Stem Cell Market Share by Country (2016-2027)
Figure 24. United States Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Stem Cell Market Share by Type (2016-2027)
Figure 28. Europe Cancer Stem Cell Market Share by Application (2016-2027)
Figure 29. Europe Cancer Stem Cell Market Share by Country (2016-2027)
Figure 30. Germany Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Stem Cell Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cancer Stem Cell Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cancer Stem Cell Market Share by Region (2016-2027)
Figure 40. China Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Stem Cell Market Share by Type (2016-2027)
Figure 48. Latin America Cancer Stem Cell Market Share by Application (2016-2027)
Figure 49. Latin America Cancer Stem Cell Market Share by Country (2016-2027)
Figure 50. Mexico Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Stem Cell Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cancer Stem Cell Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cancer Stem Cell Market Share by Country (2016-2027)
Figure 56. Turkey Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 60. AbbVie, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 61. Merck KGaA Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 62. Bionomics Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 63. Lonza Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 64. Stemline Therapeutics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 65. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 66. PromoCell GmbH Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 67. MacroGenics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 68. OncoMed Pharmaceuticals, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 69. Irvine Scientific Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 70. STEMCELL Technologies Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 71. Sino Biological Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 72. BIOTIME, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---